Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Differences between the United States and the European Union in the time of approval of CFTR modulators for the treatment of cystic fibrosis

Differences between the United States and the European Union in the time of approval of CFTR modulators for the treatment of cystic fibrosis

Resource Type

CF Research News

Authors

Enrico Costa, Silvia Girotti, Clément Mathieu, Carlo Castellani, Joseph S Ross, Jennifer L. Taylor-Cousar, Hubert G. M. Leufkens

References

J Cyst Fibros. 2024 Aug 24:S1569-1993(24)00828-2. doi: 10.1016/j.jcf.2024.08.002.

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFTR modulators [3]
European Medicines Agency [4]
Food and Drug Administration [5]
Times of approval [6]
Times of submission [7]

Date

Saturday, August 24, 2024

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/differences-between-united-states-and-european-union-time-approval

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-24-00203R2_FINAL_Costa_220924.pdf [2] https://pubmed.ncbi.nlm.nih.gov/39183127/ [3] https://www.ecfs.eu/research-article-keywords/cftr-modulators [4] https://www.ecfs.eu/research-article-keywords/european-medicines-agency [5] https://www.ecfs.eu/research-article-keywords/food-and-drug-administration [6] https://www.ecfs.eu/research-article-keywords/times-approval [7] https://www.ecfs.eu/research-article-keywords/times-submission [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines